Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (18) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Jarosch, Ernst Dr. (2) Kieback, Elisa Dr. (1) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Quensel, Christina Dr. (1) Rajewsky, Nikolaus Prof. Dr. (2) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Sommer, Thomas Prof. Dr. (9) Uckert, Wolfgang Prof. Dr. (4) Willimsky, Gerald Dr. (3) Wolf, Jana Prof. Dr. (1) (-) Kammertöns, Thomas Dr. (5) (-) Nguyen, Tam Hoai Dr. (1) 1998 (1) 1999 (1) 2000 (3) 2001 (1) 2002 (2) 2003 (1) (-) 2004 (5) 2005 (4) 2007 (1) 2009 (3) 2010 (1) (-) 2011 (2) 2012 (4) 2013 (4) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2019 (2) 2020 (3) 2022 (2) 2023 (1) Epigenetic Regulation and Chromatin Architecture (8) (-) Intracellular Proteolysis (1) (-) Molecular Immunology and Gene Therapy (6) 7 Results: Active Filter: Kammertöns, Thomas Dr.Nguyen, Tam Hoai Dr.Intracellular ProteolysisMolecular Immunology and Gene Therapy20042011 Sort: Result score Newest to oldest Oldest to newest January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto January 01, 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens December 13, 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer
January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
January 01, 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
December 13, 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein